Democrats gain Senate control, raising uncertainty for Trump-era health policies

Democrats have won control of the Senate, giving them the authority to challenge and potentially reverse health care policies enacted during the Trump administration, according to STAT. The new balance of power could influence decisions on regulation, funding, and oversight in the sector.

This development matters for healthcare and pharma executives, as it may lead to changes in compliance requirements and market access. Policy shifts could affect existing strategies and require adjustments to ongoing programmes or investments. Leaders should monitor forthcoming legislative activity for potential impacts.